On International Women’s Day, pharmaphorum looks back to an interview with Miruna Sasu, PhD, CEO of COTA, a real-world data company that is advancing generative AI models for cancer care.
In the latest episode of the pharmaphorum podcast, editor in chief Jonah Comstock speaks with Miruna Sasu, chief strategy officer of COTA and long-time pharma vet-- before joining COTA last
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh